Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of Safety and Immunogenicity of BNT162B2 mRNA COVID-19 Vaccine in IBD Pediatric Population with Distinct Immune Suppressive Regimens.
Cotugno N, Franzese E, Angelino G, Amodio D, Romeo EF, Rea F, Faraci S, Tambucci R, Profeti E, Manno EC, Santilli V, Rotulo GA, Pighi C, Medri C, Morrocchi E, Colagrossi L, Pascucci GR, Valentini D, Villani A, Rossi P, De Angelis P, Palma P. Cotugno N, et al. Among authors: medri c. Vaccines (Basel). 2022 Jul 11;10(7):1109. doi: 10.3390/vaccines10071109. Vaccines (Basel). 2022. PMID: 35891273 Free PMC article.
Perinatally Human Immunodeficiency Virus-Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity.
Morrocchi E, Pighi C, Pascucci GR, Cotugno N, Medri C, Amodio D, Colagrossi L, Ruggiero A, Manno EC, Casamento Tumeo C, Bernardi S, Smolen KK, Perno CF, Ozonoff A, Rossi P, Levy O, Palma P. Morrocchi E, et al. Among authors: medri c. Clin Infect Dis. 2022 Aug 15;75(Suppl 1):S51-S60. doi: 10.1093/cid/ciac408. Clin Infect Dis. 2022. PMID: 35738253 Free PMC article.
Humoral and Cellular Response Following Vaccination With the BNT162b2 mRNA COVID-19 Vaccine in Patients Affected by Primary Immunodeficiencies.
Amodio D, Ruggiero A, Sgrulletti M, Pighi C, Cotugno N, Medri C, Morrocchi E, Colagrossi L, Russo C, Zaffina S, Di Matteo G, Cifaldi C, Di Cesare S, Rivalta B, Pacillo L, Santilli V, Giancotta C, Manno EC, Ciofi Degli Atti M, Raponi M, Rossi P, Finocchi A, Cancrini C, Perno CF, Moschese V, Palma P. Amodio D, et al. Among authors: medri c. Front Immunol. 2021 Oct 4;12:727850. doi: 10.3389/fimmu.2021.727850. eCollection 2021. Front Immunol. 2021. PMID: 34671350 Free PMC article.
BNT162B2 mRNA COVID-19 Vaccine in Heart and Lung Transplanted Young Adults: Is an Alternative SARS-CoV-2 Immune Response Surveillance Needed?
Cotugno N, Pighi C, Morrocchi E, Ruggiero A, Amodio D, Medri C, Colagrossi L, Russo C, Di Cesare S, Santilli V, Manno EC, Zangari P, Giancotta C, Bernardi S, Nicolosi L, Ciofi Degli Atti M, Raponi M, Zaffina S, Alfieri S, Kirk R, Perno CF, Rossi P, Amodeo A, Palma P. Cotugno N, et al. Among authors: medri c. Transplantation. 2022 Feb 1;106(2):e158-e160. doi: 10.1097/TP.0000000000003999. Transplantation. 2022. PMID: 34954734 No abstract available.
Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies.
Cotugno N, Ruggiero A, Bonfante F, Petrara MR, Zicari S, Pascucci GR, Zangari P, De Ioris MA, Santilli V, Manno EC, Amodio D, Bortolami A, Pagliari M, Concato C, Linardos G, Campana A, Donà D, Giaquinto C; CACTUS Study Team; Brodin P, Rossi P, De Rossi A, Palma P. Cotugno N, et al. Cell Rep. 2021 Mar 16;34(11):108852. doi: 10.1016/j.celrep.2021.108852. Cell Rep. 2021. PMID: 33730580 Free PMC article.
Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy.
Ruggiero A, Pascucci GR, Cotugno N, Domínguez-Rodríguez S, Rinaldi S, Tagarro A, Rojo P, Foster C, Bamford A, De Rossi A, Nastouli E, Klein N, Morrocchi E, Fatou B, Smolen KK, Ozonoff A, Di Pastena M, Luzuriaga K, Steen H, Giaquinto C, Goulder P, Rossi P, Levy O, Pahwa S, Palma P; EPIICAL Consortium. Ruggiero A, et al. Front Immunol. 2022 Mar 31;13:860418. doi: 10.3389/fimmu.2022.860418. eCollection 2022. Front Immunol. 2022. PMID: 35432380 Free PMC article.
How CD4+ T Cells Transcriptional Profile Is Affected by Culture Conditions: Towards the Design of Optimal In Vitro HIV Reactivation Assays.
Pascucci GR, Morrocchi E, Pighi C, Rotili A, Neri A, Medri C, Olivieri G, Sanna M, Rasi G, Persaud D, Chahroudi A, Lichterfeld M, Nastouli E, Cancrini C, Amodio D, Rossi P, Cotugno N, Palma P. Pascucci GR, et al. Among authors: medri c. Biomedicines. 2023 Mar 13;11(3):888. doi: 10.3390/biomedicines11030888. Biomedicines. 2023. PMID: 36979867 Free PMC article.
Hematocrit Self-Testing in Patients with Polycythemia Vera and Other Hematological Conditions: Assessing the Accuracy of the StatStrip Xpress® 2 LAC/Hb/Hct Device and User Opinion about the Device in Real-World Clinical Practice.
Rovó A, Baierlein-Leimbach C, Medri C, Chanias I, Errass L, Fehr T, Triemer T, McCarthy-Pontier DB, Lehmann T. Rovó A, et al. Among authors: medri c. J Clin Med. 2022 Jul 21;11(14):4234. doi: 10.3390/jcm11144234. J Clin Med. 2022. PMID: 35887998 Free PMC article.
Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy.
Sidler D, Born A, Schietzel S, Horn MP, Aeberli D, Amsler J, Möller B, Njue LM, Medri C, Angelillo-Scherrer A, Borradori L, Seyed Jafari SM, Radonjic-Hoesli S, Chan A, Hoepner R, Bacher U, Mani LY, Iype JM, Suter-Riniker F, Staehelin C, Nagler M, Hirzel C, Maurer B, Moor MB. Sidler D, et al. Among authors: medri c. RMD Open. 2022 Mar;8(1):e002166. doi: 10.1136/rmdopen-2021-002166. RMD Open. 2022. PMID: 35361691 Free PMC article.
17 results